Mesa Laboratories Inc (MLAB)
- Sector
- Life Sciences Tools & Services
- Last price
- $134.60
- As of
Kresmion compiles this page from MLAB's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
MESA LABORATORIES INC /CO/ (MLAB): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-11-09.
See the full MLAB dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for MLAB on one page. Preview it with sample data, then open it live with a free account.
Preview the MLAB dossierActive events for MLAB
- mediumEarnings above estimates
Q2-2027: Beat consensus by 104.2%, EPS $0.75 vs $0.3672 estimate
- lowEarnings above estimates
Q2-2026: EPS $0.49 vs $0.0306 estimate, +0.46 on a near-zero consensus
- lowEarnings above estimates
Q1-2027: EPS $0.49 vs $0.0306 estimate, +0.46 on a near-zero consensus
- high13F: large increase
TWO SIGMA INVESTMENTS, LP added +79% to MLAB (2026Q2)
- lowEarnings above estimates
Q1-2027: EPS $2.61 vs $0.0306 estimate, +2.58 on a near-zero consensus
FREE, NO ACCOUNT
Every event on MLAB, as it fires
You are seeing 5 of 11 events recorded on MLAB since 2026-05-26.
The five above landed across 4 days. The other 6 were recorded on 3 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, MLAB
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
More data on MLAB
MLAB against its peers
MLAB's operating margin of 7.4% ranks in the 69th percentile of 23 Life Sciences Tools & Services sub-industry peers, fiscal periods ending between 2025-10-31 and 2026-06-30.
| Metric | MLAB | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 249M USD | 1.2B USD | 37 | 25 |
| Gross margin | 63.5% | 54.0% | 68 | 16 |
| Operating margin | 7.4% | -19.9% | 69 | 23 |
| Net margin | 2.7% | -8.1% | 63 | 25 |
| Return on equity | 3.6% | -12.3% | 70 | 24 |
| P / E | 110.8x | 41.7x | 83 | 8 |
| 1 year | 89.6% | 22.5% | 75 | 25 |
Peers (25): CTKB, OABI, DNA, PACB, MRVI, FTRE, ABCL, ADPT, SHC, CDXS, MXCT, SEER, TXG, BRKR, AVTR, RGEN, TECH, TEM, CRL, MEDP, ILMN, MTD, IQV, A, WAT. Fiscal periods ending between 2025-10-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (MLAB: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Cite this data
Kresmion counts the managers it follows that reported a non-option position in MLAB on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on MLAB in the last 180 days.
Upstream: SEC EDGAR filings for MLAB
Kresmion, "MESA LABORATORIES INC /CO/ (MLAB) institutional holdings and SEC filings", data as of 2026-11-14, https://kresmion.com/research/MLAB. Upstream data: SEC EDGAR filings for MLAB.
Link to this data (HTML):
<a href="https://kresmion.com/research/MLAB">MESA LABORATORIES INC /CO/ (MLAB) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow MLAB on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to MLAB for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.